Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00635154 · OUTCOME

Progression Free Survival (PFS) in Patients Treated With Anakinra Alone or in Combination With Dexamethasone

Anakinra With or Without Dexamethasone in Treating Patients With Smoldering or Indolent Multiple Myeloma · Source last updated 2018-06-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
months
Interval / dispersion
95% Confidence Interval
Time frame
Time from registration to progression or death (up to 5 years)

What was measured

PFS was defined as the time from registration to progression or death due to any cause. Progression is defined the same as outcome measure #3.

Analysis population: PFS results were published in Mayo Clin Proc, Feb 2009. 47 patients were analyzed for this publication.

Groups in this outcome

Anakinra With/Without Dexamethasone

Not reported

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Anakinra With/Without Dexamethasone47

Reported measurements

Source class 1
Values in months · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Anakinra With/Without Dexamethasone37.5Not reported9.6NAThe upper bound for the confidence interval has not been attained.
Complete source fields
classes
  1. categories
    1. measurements
      1. comment
        The upper bound for the confidence interval has not been attained.
        group Id
        OG000
        lower Limit
        9.6
        upper Limit
        NA
        value
        37.5
denoms
  1. counts
    1. group Id
      OG000
      value
      47
    units
    Participants
description
PFS was defined as the time from registration to progression or death due to any cause. Progression is defined the same as outcome measure #3.
dispersion Type
95% Confidence Interval
groups
  1. id
    OG000
    title
    Anakinra With/Without Dexamethasone
param Type
MEDIAN
population Description
PFS results were published in Mayo Clin Proc, Feb 2009. 47 patients were analyzed for this publication.
reporting Status
POSTED
time Frame
Time from registration to progression or death (up to 5 years)
title
Progression Free Survival (PFS) in Patients Treated With Anakinra Alone or in Combination With Dexamethasone
type
SECONDARY
unit Of Measure
months

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice